Chemical Structure (Synarel 01)
Synarel Spray, Metered
Product Images NDC 0025-0166
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Synarel (NDC 0025-0166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Synarel 02)
This is a label of a medication named Pfizer, distributed by Pfizer Labs, a division of Pfizer Inc. The medication is made in New York, NY 10017.*
Chemical Structure (Synarel 03)
Figure (Synarel 04)
This is a list of adverse events reported during a 6-month treatment with Synarel® 400 pg/day versus Danazol 600 or 800 mg/day. The adverse events are categorized into hypostrogenic, androgenic, local, and miscellaneous. Hypostrogenic adverse events include hot flashes, decreased libido, vaginal dryness, and insomnia. Androgenic adverse events include breast size reduction, edema, seborrhea, weight gain, hirsutism, and increased libido. Local adverse events include nasal irritation, while miscellaneous adverse events include depression and weight loss. There is also a graph showing the percentage of patients experiencing these adverse events.*
Logo (Synarel 05)
This is a label for a product distributed by Pfizer Labs, a division of Pfizer Inc. The location of the company is in New York, NY 10017.*
Figure A (Synarel 06)
Figure B (Synarel 07)
Figure C (Synarel 08)
Figure D (Synarel 09)
Figure E (Synarel 10)
Figure F (Synarel 11)
Figure G (Synarel 12)
Figure H (Synarel 13)
Figure I (Synarel 14)
Figure J (Synarel 15)
Logo (Synarel 16)
Figure A (Synarel 17)
Figure B (Synarel 18)
Figure C (Synarel 19)
Figure D (Synarel 20)
Figure E (Synarel 21)
Figure F (Synarel 22)
Figure G (Synarel 23)
Figure H (Synarel 24)
Figure I (Synarel 25)
Figure J (Synarel 26)
Figure K (Synarel 27)
Logo (Synarel 28)
This is a label with information about a medication called Pfizer. It is distributed by the Pfizer Labs division of Pfizer Inc. and is located in New York City with a zip code of 10017.*
Principal Display Panel (8 mL Bottle Label)
Principal Display Panel (8 mL Bottle Carton)
Synarel® (nafarelin acetate) nasal solution is a medication delivered intranasally with each actuation delivering approximately 200 meg nafarelin. The carton comes with a bottle of nasal solution along with spray pump, patient information, and complete prescribing information. It contains 2 mg/mL nafarelin base in benzalkonium chloride, glacial acetic acid, sodium hydroxide or hydrochloric acid (to adjust pH), sorbitol, and purified water. This medication should be stored upright at a temperature range of 15-30°C and kept away from light and children. Dosage and use details are provided in the accompanying prescribing information. This product is distributed by Pfizer Labs Division of Pfizer Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
